RonaYaegerMD

Physician

Overview of Dr. Yaeger

Dr. Rona Yaeger is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. She received her medical degree from NYU School of Medicine and has been in practice 14 years. She specializes in medical oncology.

Office
160 East 53rd Street
New York, NY 10022
Book by Phone+1(708) 627-2532

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2003 - 2006
New York University School of MedicineClass of 2003

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2004 - 2026
NJ State Medical License 2020 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Start of enrollment: 2013 Jan 01
Completed
Phase 1
This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours) Start of enrollment: 2018 Aug 08
Terminated
Phase 1

Publications & Presentations

PubMed

Author Correction: Progressive plasticity during colorectal cancer metastasis.
Andrew Moorman, Elizabeth K Benitez, Francesco Cambuli, Qingwen Jiang, Ahmed Mahmoud
Nature. 2025-01-09
ASO Visual Abstract: Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait-Comparison of Intersphincteric Resection Versus Abdominoperineal ...
Yael Feferman, Floris S Verheij, Hannah Williams, Dana M Omer, Emmanouil P Pappou
Annals of Surgical Oncology. 2025-01-01
1 citations
Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait: Comparison of Intersphincteric Resection Versus Abdominoperineal Resection.
Yael Feferman, Floris S Verheij, Hannah Williams, Dana M Omer, Emmanouil P Pappou
Annals of Surgical Oncology. 2025-01-01

Lectures

Practical Application of Tumor Mutation Analysis and Profiling
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Press Mentions

Two Positive Trials and a Breakthrough Therapy Designation for KRAS InhibitorsDecember 22nd, 2022
Stress Response Protein Links Inflammatory Disease to Colon CancerFebruary 19th, 2021
Investigators Test Breakthrough-Designated Triplet in First-Line CRCJanuary 17th, 2020
Join now to see all